Endothelial Dysfunction Clinical Trial
— RowersOfficial title:
Effect of 2000-meter Rowing Test on Parameters of Intestinal Integrity in Elite Rowers During Competitive Phase
NCT number | NCT06372262 |
Other study ID # | Rowers2022 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 1, 2022 |
Est. completion date | June 30, 2022 |
Verified date | June 2022 |
Source | Poznan University of Physical Education |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The study aimed to check the 2000m ergometer test on markers of gut permeability in the competitive phase of rowers. 18 members of the Polish rowing team took part in the study.
Status | Completed |
Enrollment | 18 |
Est. completion date | June 30, 2022 |
Est. primary completion date | June 30, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 23 Years |
Eligibility | Inclusion Criteria: - minimum five years of training, - five training sessions per week minimum, - total training time minimum of 240 minutes, - membership in the Polish Rowing Team, - finishing the 2000-meter ergometer test. Exclusion Criteria: - antibiotic therapy within the last three months, - probiotics and prebiotics within the last three months, - dietary regime, - gastrointestinal diseases. |
Country | Name | City | State |
---|---|---|---|
Poland | Poznan University of Physical Education | Poznan |
Lead Sponsor | Collaborator |
---|---|
Poznan University of Physical Education |
Poland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | I-FABP (intestinal fatty acid binding protein)to measure epithelial wall injury | I-FABP concentration measured in blood [ng/ml] using commercially available enzyme-linked immunosorbent assays | Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting), one minute after the end of the test, and after a 1-hour recovery period | |
Primary | zonulin to measure tight junction leakage | zonulin concentration measured in blood [ng/ml] using commercially available enzyme-linked immunosorbent assays | Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting), one minute after the end of the test, and after a 1-hour recovery period | |
Primary | LBP (lipopolysaccharide binding protein) to measure endotoxin | LBP concentration measured in blood [ug/ml] using commercially available enzyme-linked immunosorbent assays | Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting), one minute after the end of the test, and after a 1-hour recovery period | |
Primary | LPS (lipopolysaccharide) to measure endotoxin | LPS concentration measured in blood [EU/Ll] using commercially available enzyme-linked immunosorbent assays | Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting), one minute after the end of the test, and after a 1-hour recovery period | |
Primary | Lactic acid to measure fatigue after the race | Lactate concentration measured in capillary blood from earlobe [mmol/L] using a commercially available kit (Diaglobal, Berlin, Germany) | Blood samples was taken from earlobe at two-time points: before each stress test (after overnight fasting), one minute after the end of the test. | |
Secondary | energy | energy [kcal ]of food intake measured by 24h dietary recall | day before test | |
Secondary | fiber intake | fiber [g] intake day before the test measured by 24h dietary recall | day before test | |
Secondary | protein | protein [g] intake day before the test measured by 24h dietary recall | day before test | |
Secondary | carbohydrate | carbohydrate [g] intake day before the test measured by 24h dietary recall | day before test | |
Secondary | body mass | Body mass [kg] measured by electronic scale to the nearest 0,05 kg (Tanita BC 418 MA Tanita Corporation, Tokyo, Japan). | in the morning before the test | |
Secondary | Body composition - water | % of body water measured by electronic scale (Tanita BC 418 MA Tanita Corporation, Tokyo, Japan). | in the morning before the test | |
Secondary | Body composition - fat | % of body fat measured by electronic scale (Tanita BC 418 MA Tanita Corporation, Tokyo, Japan). | in the morning before the test | |
Secondary | Lean body mass | Lean body mass [kg] measured by electronic scale (Tanita BC 418 MA Tanita Corporation, Tokyo, Japan). | in the morning before the test |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Completed |
NCT04156711 -
Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery
|
N/A | |
Recruiting |
NCT06133634 -
Fisetin to Improve Vascular Function in Older Adults
|
Phase 1/Phase 2 | |
Completed |
NCT05872139 -
Role of Mitochondrial-derived Oxidative Stress to Promote Vascular Endothelial Dysfunction in Non-exercisers With Aging
|
N/A | |
Recruiting |
NCT04558450 -
Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)
|
N/A | |
Terminated |
NCT03325933 -
Resistance Training and Cardiometabolic Health
|
N/A | |
Not yet recruiting |
NCT05939934 -
Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal
|
N/A | |
Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
Recruiting |
NCT02334839 -
The Association Between Severity of Hypertensive Disorder During Pregnancy and Endothelial Dysfunction
|
N/A | |
Recruiting |
NCT02020044 -
Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
|
N/A | |
Completed |
NCT01691404 -
Study on the Effects of Epicatechin and Quercetin Supplementation on Vascular Function and Blood Pressure (FLAVO)
|
N/A | |
Completed |
NCT01775865 -
Targeting Inflammation to Treat Cardiovascular Aging
|
Phase 2 | |
Terminated |
NCT01412216 -
The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance
|
Phase 2 | |
Completed |
NCT01319344 -
Effect of Eplerenone on Endothelial Function in Metabolic Syndrome
|
Phase 3 | |
Completed |
NCT00987974 -
Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury
|
Phase 4 | |
Completed |
NCT00848302 -
Endothelial Function in Human Arteries
|
Early Phase 1 | |
Completed |
NCT00990730 -
Atherosclerosis in Rheumatoid Arthritis
|
N/A | |
Completed |
NCT00532844 -
A Phase 2, Pharmacokinetic (PK) Study of 6R-BH4 Alone or 6R-BH4 With Vitamin C in Subjects With Endothelial Dysfunction
|
Phase 2 | |
Completed |
NCT00376246 -
Effect of Ezetimibe on Flow-mediated Brachial Artery Reactivity in Healthy Subjects
|
Phase 4 | |
Completed |
NCT00775099 -
Combustion Derived Air Pollution and Vascular Function
|
N/A |